Sponsor pipeline

Celcuity Inc clinical trial pipeline

Get alerts when Celcuity Inc's trials change

3 active trials 2 recruiting 2 Phase 3 2 disease areas 1 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-11

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 1/2
1
Phase 3
2

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT06757634 Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive… Breast Cancer Recruiting 2026-10-09
NCT05501886 Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the… Breast Cancer Active, Not Recruiting 2026-02-10
Phase 1/2
NCT06190899 Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate… mCRPC (Metastatic Castration-resistant Prostate Cancer) Recruiting 2026-04-13

Disease areas by active trials

Breast Cancer (2) · Prostate Cancer (1)

Get alerts when Celcuity Inc's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free